[Ip-health] Webinar, Nov 25 - Monoclonal antibodies (mAbs) for the treatment and prevention of diseases: why and how to expand global access

Marcela Vieira marcelacfvieira at gmail.com
Thu Nov 12 04:12:35 PST 2020


Dear all,

We would like to invite you to the next webinar of the series organized by
the Knowledge Network for Innovation and Access to Medicines, a project of
the Global Health Centre at the Graduate Institute of Geneva, which will
take place on Wednesday, November 25,  4pm - 5pm CET / 10am - 11am EST.

We hope you will be able to join us for this discussion. The webinar will
be recorded and made available a few days after it takes place. A list of
the previous webinars of the series and their recordings and related
materials is available at: https://www.knowledgeportalia.org/webinars

---------------
*Monoclonal antibodies (mAbs) for the treatment and prevention of diseases:
why and how to expand global access*

Wednesday, November 25, 4pm - 5pm CET / 10am - 11am EST

To join the webinar, please register here:
https://us02web.zoom.us/webinar/register/2616051743847/WN_BUFvbL71SSuhA0A5TC_KOA

Speaker:
Ayesha Sitlani, Associate Vice President - Antibody Strategy, International
AIDS Vaccine Initiative (IAVI)

Research:
IAVI/Wellcome (2020). “Expanding access to monoclonal antibody-based
products: A global call to action.” -
https://www.iavi.org/news-resources/expanding-access-to-monoclonal-antibody-based-products-a-global-call-to-action

Monoclonal antibodies (mAbs) are biological products increasingly being
used to treat a number of conditions, from cancers to Ebola to autoimmune
disorders. They are also promising candidates for the treatment and
prevention of many others, including COVID-19 and HIV. However, their high
prices consume large portions of health budgets in countries where they are
available. In many LMICs, they are not widely available at all. Increasing
access to mAbs is an issue likely to rise on the global health agenda.
Doing so will require action on many fronts in a complex global system.
Improving broader understanding of the access challenges specific to mAbs
is critical.

Ayesha Sitlani, principal investigator of a comprehensive study on mAbs
recently published by IAVI and the Wellcome Trust, will present the key
findings. The report investigated the current availability of mAbs
worldwide and the main barriers impeding broader access. She will present
potential solutions to overcoming these barriers, including: reducing
development and manufacturing costs, expanding production, encouraging
registration, developing new business models that reduce prices and
prioritize access, and expanding procurement and delivery models.

The webinar is free and open to the public and will be held in English.
Participants will be able to pose questions orally or in writing, and the
speakers will respond to a selection of these during the second half of the
event. Recordings of all webinars will be made available afterward at the
Knowledge Portal on Innovation and Access to Medicines (
www.knowledgeportalia.org), a project of the Global Health Centre, Graduate
Institute of Geneva. After registering, you will receive a confirmation
email with additional information on how to join the webinar using the Zoom
platform. For more information on the activities of the Global Health
Centre, visit our website or subscribe to our mailing list:
graduateinstitute.ch/globalhealth.

---
Marcela Vieira, LLB, MPH
Researcher and Project Coordinator of the
Knowledge Network for Innovation and Access to Medicines
https://www.knowledgeportalia.org/

Global Health Centre, Research
Graduate Institute of International and Development Studies
marcela.vieira at graduateinstitute.ch
http://www.graduateinstitute.ch/globalhealth


More information about the Ip-health mailing list